Medical journey of patients with polycystic ovary syndrome and obesity: a cross-sectional survey of patients and primary care physicians

References

• Azziz R, Carmina E, Chen Z, et al. Polycystic ovary syndrome. Nat Rev Dis Primers. 2016 Aug 11;2(1):16057.
   PubMed Web of Science ®Google Scholar
• Escobar-Morreale HF. Polycystic ovary syndrome: definition, aetiology, diagnosis and treatment. Nat Rev Endocrinol. 2018 May;14(5):270–284.
   PubMed Web of Science ®Google Scholar
• Rotterdam. Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome. Fertil Steril. 2004 Jan;81(1):19–25.
   Web of Science ®Google Scholar
• Hart R, Doherty DA. The potential implications of a PCOS diagnosis on a woman’s long-term health using data linkage. J Clin Endocrinol Metab. 2015 Mar;100(3):911–919.
   PubMed Web of Science ®Google Scholar
• Jason J. Polycystic ovary syndrome in the United States: clinical visit rates, characteristics, and associated health care costs. Arch Intern Med. 2011 Jul 11;171(13):1209–1211.
   PubMedGoogle Scholar
• Azziz R, Marin C, Hoq L, et al. Health care-related economic burden of the polycystic ovary syndrome during the reproductive life span. J Clin Endocrinol Metab. 2005 Aug;90(8):4650–4658.
   PubMed Web of Science ®Google Scholar
• Palomba S, de Wilde MA, Falbo A, et al. Pregnancy complications in women with polycystic ovary syndrome. Hum Reprod Update. 2015;21(5):575–592.
   PubMed Web of Science ®Google Scholar
• Cooney LG, Lee I, Sammel MD, et al. High prevalence of moderate and severe depressive and anxiety symptoms in polycystic ovary syndrome: a systematic review and meta-analysis. Hum Reprod. 2017 May 1;32(5):1075–1091.
   PubMed Web of Science ®Google Scholar
• Cooney LG, Dokras A. Beyond fertility: polycystic ovary syndrome and long-term health. Fertil Steril. 2018 Oct;110(5):794–809.
   PubMed Web of Science ®Google Scholar
• Gilbert EW, Tay CT, Hiam DS, et al. Comorbidities and complications of polycystic ovary syndrome: an overview of systematic reviews. Clin Endocrinol (Oxf). 2018 Dec;89(6):683–699.
   PubMed Web of Science ®Google Scholar
• Lim SS, Davies MJ, Norman RJ, et al. Overweight, obesity and central obesity in women with polycystic ovary syndrome: a systematic review and meta-analysis. Hum Reprod Update. 2012;18(6):618–637.
   PubMed Web of Science ®Google Scholar
• Azziz R, Carmina E, Dewailly D, et al. Positions statement: criteria for defining polycystic ovary syndrome as a predominantly hyperandrogenic syndrome: an androgen excess society guideline. J Clin Endocrinol Metab. 2006 Nov;91(11):4237–4245.
   PubMed Web of Science ®Google Scholar
• Mathur R, Alexander CJ, Yano J, et al. Use of metformin in polycystic ovary syndrome. Am J Obstet Gynecol. 2008 Dec;199(6):596–609.
   PubMed Web of Science ®Google Scholar
• DeUgarte CM, Bartolucci AA, Azziz R. Prevalence of insulin resistance in the polycystic ovary syndrome using the homeostasis model assessment. Fertil Steril. 2005 May;83(5):1454–1460.
   PubMed Web of Science ®Google Scholar
• Escobar-Morreale HF, San Millán JL. Abdominal adiposity and the polycystic ovary syndrome. Trends Endocrinol Metab. 2007 Sep;18(7):266–272.
   PubMed Web of Science ®Google Scholar
• Matsuzawa Y, Funahashi T, Nakamura T. The concept of metabolic syndrome: contribution of visceral fat accumulation and its molecular mechanism. J Atheroscler Thromb. 2011;18(8):629–639.
   PubMed Web of Science ®Google Scholar
• Mendrick DL, Diehl AM, Topor LS, et al. Metabolic syndrome and associated diseases: from the bench to the clinic. Toxicol Sci. 2018;162(1):36–42.
   PubMed Web of Science ®Google Scholar
• Rojas J, Chávez M, Olivar L, et al. Polycystic ovary syndrome, insulin resistance, and obesity: navigating the pathophysiologic labyrinth. Int J Reprod Med. 2014;2014:719050.
   PubMedGoogle Scholar
• Johansson J, Stener-Victorin E. Polycystic ovary syndrome: effect and mechanisms of acupuncture for ovulation induction. Evid Based Complement Alternat Med. 2013;2013:762615.
   PubMed Web of Science ®Google Scholar
• Gibson-Helm M, Teede H, Dunaif A, et al. Delayed diagnosis and a lack of information associated with dissatisfaction in women with polycystic ovary syndrome. J Clin Endocrinol Metab. 2017 Feb 1;102(2):604–612.
   PubMed Web of Science ®Google Scholar
• Hoyos LR, Putra M, Armstrong AA, et al. Measures of patient dissatisfaction with health care in polycystic ovary syndrome: retrospective analysis. J Med Internet Res. 2020 Apr 21;22(4):e16541.
   PubMed Web of Science ®Google Scholar
• Lin AW, Bergomi EJ, Dollahite JS, et al. Trust in physicians and medical experience beliefs differ between women with and without polycystic ovary syndrome. J Endocr Soc. 2018;2(9):1001–1009.
   PubMed Web of Science ®Google Scholar
• Roe AH, Dokras A. The diagnosis of polycystic ovary syndrome in adolescents. Rev Obstet Gynecol. Summer 2011;4(2):45–51.
   PubMedGoogle Scholar
• de Melo AS, Dos Reis RM, Ferriani RA, et al. Hormonal contraception in women with polycystic ovary syndrome: choices, challenges, and noncontraceptive benefits. Open Access J Contracept. 2017;8:13–23.
   PubMed Web of Science ®Google Scholar
• Ismayilova M, Yaya S. “I felt like she didn’t take me seriously”: a multi-methods study examining patient satisfaction and experiences with polycystic ovary syndrome (PCOS) in Canada. BMC Women's Health. 2022 Feb 23;22(1):47.
   PubMed Web of Science ®Google Scholar
• Ismayilova M, Yaya S. ‘I’m usually being my own doctor’: women’s experiences of managing polycystic ovary syndrome in Canada. Int Health. 2022 May 14:ihac028.
   PubMed Web of Science ®Google Scholar
• ACOG. ACOG practice bulletin No. 194 summary: polycystic ovary syndrome. Obstet Gynecol. 2018 Jun;131(6):1174–1176.
   PubMed Web of Science ®Google Scholar
• Rosenfield RL, Ehrmann DA. The pathogenesis of Polycystic Ovary Syndrome (PCOS): the hypothesis of PCOS as functional ovarian hyperandrogenism revisited. Endocr Rev. 2016 Oct;37(5):467–520.
   PubMed Web of Science ®Google Scholar
• Godoy-Matos AF, Silva Júnior WS, Valerio CM. NAFLD as a continuum: from obesity to metabolic syndrome and diabetes. Diabetol Metab Syndr. 2020 July 14;12(1):60.
   PubMed Web of Science ®Google Scholar
• Kumarendran B, O’Reilly MW, Manolopoulos KN, et al. Polycystic ovary syndrome, androgen excess, and the risk of nonalcoholic fatty liver disease in women: a longitudinal study based on a United Kingdom primary care database. PLoS Med. 2018 Mar;15(3):e1002542.
   PubMed Web of Science ®Google Scholar
• Ando Y, Jou JH. Nonalcoholic fatty liver disease and recent guideline updates. Clin Liver Dis. 2021 Jan 01;17(1):23–28.
   Google Scholar
• Kaur I, Suri V, Rana SV, et al. Treatment pathways traversed by polycystic ovary syndrome (PCOS) patients: a mixed-method study. PLoS One. 2021;16(8):e0255830.
   PubMed Web of Science ®Google Scholar
• Tak YJ, Lee SY. Long-term efficacy and safety of anti-obesity treatment: where do we stand? Curr Obes Rep. 2021;10(1):14–30.
   PubMed Web of Science ®Google Scholar
• Yanes Cardozo LL, Romero DG. Management of cardiometabolic complications in polycystic ovary syndrome: unmet needs. Faseb J. 2021 Nov;35(11):e21945.
   PubMed Web of Science ®Google Scholar
• Garvey WT, Mechanick JI, Brett EM, et al. American association of clinical endocrinologists and American College of endocrinology comprehensive clinical practice guidelines for medical care of patients with obesity. Endocr Pract. 2016 Jul;22(Suppl 3):1–203.
   PubMed Web of Science ®Google Scholar
• Barrea L, Frias-Toral E, Verde L, et al. PCOS and nutritional approaches: differences between lean and obese phenotype. Metabol Open.2021Dec;12:100123
   PubMedGoogle Scholar
• Neves LPP, Marcondes RR, Maffazioli GN, et al. Nutritional and dietary aspects in polycystic ovary syndrome: insights into the biology of nutritional interventions. Gynecol Endocrinol. 2020 Dec;36(12):1047–1050.
   PubMed Web of Science ®Google Scholar
• Frias-Toral E, Garcia-Velasquez E, de Los Angeles Carignano M, et al. Polycystic ovary syndrome and obesity: clinical aspects and nutritional management. Minerva Endocrinol (Torino). 2022 Jun;47(2):215–241
   PubMed Web of Science ®Google Scholar
• Elkind-Hirsch KE, Chappell N, Shaler D, et al. Liraglutide 3 mg on weight, body composition, and hormonal and metabolic parameters in women with obesity and polycystic ovary syndrome: a randomized placebo-controlled-phase 3 study. Fertil Steril. 2022;118(2):371–381.
   PubMed Web of Science ®Google Scholar
• Short ME, Goetzel RZ, Pei X, et al. How accurate are self-reports? Analysis of self-reported health care utilization and absence when compared with administrative data. J Occup Environ Med. 2009 Jul;51(7):786–796.
   PubMed Web of Science ®Google Scholar